Security Snapshot

SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) Institutional Ownership

CUSIP: 834203309

13F Institutional Holders and Ownership History from Q3 2022 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

224

Shares (Excl. Options)

62,216,756

Price

$33.48

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-3,046,220
Value change
-$135,503,176
Number of holders
224
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
51,293,400
SEC-reported price per share
$53.01
Insider filing price
$53.01
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SLNO - SOLENO THERAPEUTICS INC - COMMON STOCK is tracked under CUSIP 834203309.
  • 224 institutions reported positions in Q1 2026.
  • 11 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 247 to 224 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $3,006,117,784 to $2,080,448,333.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 224 institutions filings for Q1 2026.

Open SEC evidence

Security key

834203309

Latest holder period

Q1 2026

13F holders

224

13D/G owners

11

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
11
Security
SLNO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 8.6% +40% $232,450,270 +$57,970,095 4,426,781 +33% Wellington Management Group LLP 31 Mar 2026
BlackRock, Inc. 6.9% +23% $118,629,904 +$26,016,415 3,543,296 +28% BlackRock, Inc. 31 Mar 2026
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.4% $204,422,873 2,775,976 Adage Capital Management, L.P. 31 Dec 2024
STATE STREET CORP 5.2% $140,768,913 2,680,802 STATE STREET CORPORATION 31 Mar 2026
Avoro Capital Advisors LLC 4.4% -19% $120,773,000 -$31,506,000 2,300,000 -21% Avoro Capital Advisors LLC 31 Mar 2026
Vivo Opportunity Fund Holdings, L.P. 4.2% -46% $152,178,416 -$115,402,258 2,251,160 -43% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
Adage Capital Management, L.P. 2.6% -64% $94,746,538 -$146,988,629 1,401,576 -61% Adage Capital Management, L.P. 30 Sep 2025
JANUS HENDERSON GROUP PLC 2.3% -85% $63,290,461 -$313,644,908 1,205,303 -83% JANUS HENDERSON GROUP PLC 30 Apr 2026
PRICE T ROWE ASSOCIATES INC /MD/ 2% -70% $53,868,329 -$127,895,561 1,025,868 -70% T. Rowe Price Associates, Inc. 31 Mar 2026
Nantahala Capital Management, LLC 2% -60% $86,766,978 -$140,918,982 1,001,350 -62% Nantahala Capital Management, LLC 30 Jun 2025
FMR LLC 0.4% -98% $10,135,145 -$292,764,044 193,014 -97% FMR LLC 30 Apr 2026

As of 31 Mar 2026, 224 institutional investors reported holding 62,216,756 shares of SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO). This represents 121% of the company’s total 51,293,400 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
88%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 14% 7,099,328 -1.1% 0.11% $237,631,668
FMR LLC 11% 5,788,410 -28% 0.01% $193,795,955
WELLINGTON MANAGEMENT GROUP LLP 8.6% 4,426,781 +33% 0.03% $148,208,627
BlackRock, Inc. 7.3% 3,742,774 -3.3% 0% $125,308,074
STATE STREET CORP 5.2% 2,680,802 +1.2% 0% $89,753,251
Avoro Capital Advisors LLC 4.5% 2,300,000 -21% 0.76% $77,004,000
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 2,153,218 0% 0% $72,089,739
Nantahala Capital Management, LLC 3.4% 1,744,124 +33% 3.6% $58,393,272
Polar Capital Holdings Plc 3.3% 1,698,855 +49% 0.25% $56,877,665
Khrom Capital Management LLC 2.9% 1,511,481 4.6% $50,604,384
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,237,550 +6.4% 0% $41,440,562
Woodline Partners LP 2.2% 1,112,104 +0.03% 0.14% $37,233,242
Deep Track Capital, LP 2.1% 1,078,710 +7.9% 0.75% $36,115,211
PRICE T ROWE ASSOCIATES INC /MD/ 2% 1,025,937 -69% 0% $34,350,000
BRAIDWELL LP 1.9% 959,259 -19% 1.1% $32,115,991
READYSTATE ASSET MANAGEMENT LP 1.9% 952,165 +8.9% 1.9% $31,878,484
FRANKLIN RESOURCES INC 1.6% 835,178 +1.4% 0.01% $27,961,773
Vestal Point Capital, LP 1.4% 730,000 0.68% $24,440,400
Commodore Capital LP 1.3% 652,432 -46% 1.3% $21,843,423
SCHRODER INVESTMENT MANAGEMENT GROUP 1.3% 648,827 +44% 0.02% $19,750,294
Hood River Capital Management LLC 1.2% 623,421 +0.88% 0.21% $20,872,135
Pictet Asset Management Holding SA 1.2% 616,217 -1.3% 0.02% $20,630,945
MILLENNIUM MANAGEMENT LLC 1.2% 606,513 -51% 0.02% $20,306,055
Catalio Capital Management, LP 1.1% 577,808 +60% 4% $19,345,012
KINGDON CAPITAL MANAGEMENT, L.L.C. 1.1% 575,000 +44% 3.2% $19,251,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
15
Latest
Q1 2026
Rows shown
1-15 of 15
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 62,216,756 $2,080,448,333 -$135,503,176 $33.48 224
2025 Q4 64,916,991 $3,006,117,784 -$193,286,405 $46.30 247
2025 Q3 65,165,847 $4,403,391,909 +$507,196,048 $67.60 237
2025 Q2 56,749,470 $4,754,316,405 +$213,454,357 $83.78 231
2025 Q1 54,568,286 $3,901,554,193 +$304,734,926 $71.45 215
2024 Q4 51,039,620 $2,293,782,533 +$169,954,638 $44.95 164
2024 Q3 47,119,847 $2,378,750,710 +$200,292,187 $50.49 140
2024 Q2 43,315,547 $1,767,618,917 +$339,170,617 $40.80 112
2024 Q1 34,986,278 $1,496,099,214 +$153,335,358 $42.80 97
2023 Q4 31,409,972 $1,264,282,488 +$428,860,586 $40.25 76
2023 Q3 20,301,195 $598,794,549 +$451,363,927 $29.51 54
2023 Q2 4,852,710 $20,757,863 +$7,837,293 $4.29 22
2023 Q1 3,071,637 $6,538,076 +$3,161,387 $2.14 20
2022 Q4 2,785,956 $5,517,109 +$81,616 $1.98 22
2022 Q3 2,781,988 $4,645,586 +$4,630,000 $1.67 14
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .